| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/13/1996 | EP0528932B1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis |
| 03/13/1996 | EP0491007B1 Structural alterations of the egf receptor gene in human gliomas |
| 03/13/1996 | EP0436598B1 Cell sorting technique and applications thereof |
| 03/13/1996 | EP0436545B1 Therapeutic methods using catalytic antibodies |
| 03/13/1996 | EP0435911B1 Cell culture medium for enhanced cell growth, culture longevity and product expression |
| 03/13/1996 | CN1118609A Plant virus resistance conferring polyribozyme and resistant plants producing same |
| 03/12/1996 | US5498830 Decreased oil content in plant seeds |
| 03/12/1996 | US5498697 Protein possessing metastasis-inhibitory activity |
| 03/12/1996 | US5498544 Method and an acetyl CoA carboxylase gene for conferring herbicide tolerance |
| 03/12/1996 | US5498540 Method for culturing insect cells in a medium containing fish serum |
| 03/12/1996 | US5498499 Peptides and antibodies that inhibit platelet adhesion |
| 03/10/1996 | CA2145905A1 Anti-thymosin .alpha.1 monoclonal antibody-producing hybridoma |
| 03/07/1996 | WO1996007097A1 Cell separation apparatus and method |
| 03/07/1996 | WO1996007096A1 AN IN VITRO SYSTEM FOR DETERMINING FORMATION OF Aβ AMYLOID |
| 03/07/1996 | WO1996006937A1 Improvements in production of proteins in host cells |
| 03/07/1996 | WO1996006936A1 Nucleotides sequences of canola and soybean palmitoyl-acp thioesterase genes and their use in the regulation of fatty acid content of the oils of soybean and canola plants |
| 03/07/1996 | WO1996006935A2 Arabinoxylan degrading enzymes |
| 03/07/1996 | WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 03/07/1996 | WO1996006932A1 Plant transcription regulators from circovirus |
| 03/07/1996 | WO1996006929A2 Rapid expansion method ('rem') for in vitro propagation of t lymphocytes |
| 03/07/1996 | WO1996006928A1 A method of selecting pluripotent hematopoietic progenitor cells |
| 03/07/1996 | WO1996006927A1 Transgenic animal expressing a familial form of human amyloid precursor protein |
| 03/07/1996 | WO1996006862A1 Gabaa receptor epsilon subunit |
| 03/07/1996 | WO1996004393A3 Control of plant gene expression |
| 03/07/1996 | WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/07/1996 | WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy |
| 03/07/1996 | DE4431598A1 Implant prepn., esp. for cartilage repair |
| 03/07/1996 | DE19531931A1 Modulatoren des Körpergewichts, korrespondierende Nukleinsäuren und Proteine, und diagnostische und therapeutische Verwendungen derselben Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 03/07/1996 | CA2198891A1 Genetically modified t cells |
| 03/07/1996 | CA2198451A1 Transgenic animal expressing a familial form of human amyloid precursor protein |
| 03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
| 03/07/1996 | CA2197774A1 A method of selecting pluripotent hematopoietic progenitor cells |
| 03/07/1996 | CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 03/07/1996 | CA2174844A1 Arabinoxylan degrading enzymes |
| 03/06/1996 | EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 03/06/1996 | EP0699758A1 Prototype felv isolates for use in disease models and vaccines |
| 03/06/1996 | EP0699757A1 Potyvirus coat protein genes and plants transformed therewith |
| 03/06/1996 | EP0699754A1 Method for diagnosing a predisposition for breast and ovarian cancer |
| 03/06/1996 | EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses |
| 03/06/1996 | EP0699240A1 Gibbon ape leukemia virus-based retroviral vectors |
| 03/06/1996 | EP0699239A1 Genetic stabilizing elements |
| 03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 03/06/1996 | EP0699235A1 Animal model for hepatitis virus infection |
| 03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
| 03/06/1996 | EP0699077A1 Hiv immunogenic complexes |
| 03/06/1996 | EP0699076A1 Otitis media vaccine |
| 03/06/1996 | EP0699073A1 Allogeneic and xenogeneic transplantation |
| 03/06/1996 | EP0699023A1 Enhanced insect resistance in plants genetically engineered with a plant hormone gene involved in cytokinin biosynthesis |
| 03/06/1996 | EP0505397B1 Method of making factor-dependent human b cell lines |
| 03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
| 03/06/1996 | CN1118172A Oxidatively stable alpha-amylase |
| 03/06/1996 | CN1118008A Erythropoietin for human |
| 03/05/1996 | US5496934 Nucleic acids encoding a cellulose binding domain |
| 03/05/1996 | US5496732 Dna sequence encoding isopentenyl transferase |
| 03/05/1996 | US5496731 Anti-oncogenes |
| 03/05/1996 | US5496722 Method for producing non-neoplastic, three dimensional, mammalian tissue and cell aggregates under microgravity culture conditions and the products produced therefrom |
| 03/05/1996 | US5496720 Increasing intracellular calcium levels; phosphorylation prevention |
| 03/04/1996 | EP0711347A4 Ph genes and their uses |
| 02/29/1996 | WO1996006176A1 Functional modified hsv1-tk |
| 02/29/1996 | WO1996006175A2 Fumonisin-detoxifying enzymes |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006168A2 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | WO1996006167A1 Glutamate receptor |
| 02/29/1996 | WO1996006165A1 Genetically engineered swine cells |
| 02/29/1996 | WO1996006162A1 HYBRIDOMA THAT EXPRESSES mRNA OF INTERLEUKIN-5 AND METHOD OF SCREENING DRUGS THEREWITH |
| 02/29/1996 | WO1996006161A1 Establishment of trichoplusia ni cell lines in serum-free medium for recombinant protein and baculovirus production |
| 02/29/1996 | WO1996006160A1 Method of culturing avian cells and cell line obtained thereby |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | WO1996006113A1 New immunocontraceptive peptides |
| 02/29/1996 | WO1996006111A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | WO1996006097A1 New multimerizing agents |
| 02/29/1996 | WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 02/29/1996 | WO1996001614A3 Rna component of telomerase |
| 02/29/1996 | WO1996001324A3 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 02/29/1996 | DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other |
| 02/29/1996 | CA2198265A1 New immunocontraceptive peptides |
| 02/29/1996 | CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/29/1996 | CA2197890A1 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | CA2197242A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | CA2196997A1 Glutamate receptor |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | CA2196311A1 Genetically engineered swine cells |
| 02/28/1996 | EP0698665A2 Infectious Tick-Borne Encephalitis virus cDNA clone, recombinant vaccine derived therefrom and preparation thereof |
| 02/28/1996 | EP0698117A1 Monoclonal antibodies against ck-mb |
| 02/28/1996 | EP0698107A1 Gene therapy for haemophilia |
| 02/28/1996 | EP0698106A1 Marker gene |
| 02/28/1996 | EP0698103A1 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE |
| 02/28/1996 | EP0698096A1 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 02/28/1996 | EP0698095A1 Bmp-10 compositions |
| 02/28/1996 | EP0698094A1 Bmp-11 compositions |
| 02/28/1996 | EP0698093A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 02/28/1996 | EP0698092A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 02/28/1996 | EP0698089A1 Nucleic acid encoding amp-activated protein kinase |
| 02/28/1996 | EP0698087A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer |
| 02/28/1996 | EP0698085A1 Flow-through bioreactor with grooves for cell retention |
| 02/28/1996 | EP0697916A1 Method and apparatus for semi-automated cell separation |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |